DE602006015438D1 - Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür - Google Patents

Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Info

Publication number
DE602006015438D1
DE602006015438D1 DE602006015438T DE602006015438T DE602006015438D1 DE 602006015438 D1 DE602006015438 D1 DE 602006015438D1 DE 602006015438 T DE602006015438 T DE 602006015438T DE 602006015438 T DE602006015438 T DE 602006015438T DE 602006015438 D1 DE602006015438 D1 DE 602006015438D1
Authority
DE
Germany
Prior art keywords
probiotic
food
glukan
food product
isolated beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006015438T
Other languages
English (en)
Inventor
Barry R Goldin
Sherwood L Gorbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602006015438D1 publication Critical patent/DE602006015438D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/18—Milk in dried and compressed or semi-solid form
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
    • A23L7/10—Cereal-derived products
    • A23L7/115—Cereal fibre products, e.g. bran, husk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pediatric Medicine (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE602006015438T 2005-02-15 2006-02-15 Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür Active DE602006015438D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65293505P 2005-02-15 2005-02-15
PCT/US2006/005271 WO2006088923A2 (en) 2005-02-15 2006-02-15 A food containing a probiotic and an isolated beta-glucan and methods of use thereof

Publications (1)

Publication Number Publication Date
DE602006015438D1 true DE602006015438D1 (de) 2010-08-26

Family

ID=36917003

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006015438T Active DE602006015438D1 (de) 2005-02-15 2006-02-15 Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Country Status (10)

Country Link
US (2) US7981412B2 (de)
EP (2) EP1858340B1 (de)
JP (1) JP4777365B2 (de)
KR (1) KR101355266B1 (de)
AT (1) ATE473636T1 (de)
AU (1) AU2006214382C1 (de)
DE (1) DE602006015438D1 (de)
DK (1) DK1858340T3 (de)
ES (1) ES2348403T3 (de)
WO (1) WO2006088923A2 (de)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
CN101184780B (zh) 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
PL1965809T3 (pl) 2005-11-21 2010-02-26 Bioatlantis Ltd Kompozycje do poprawiania zdrowia jelit i użytkowości zwierząt zawierające beta-glukany i alfa-fukany
TW200808191A (en) 2006-08-09 2008-02-16 Genmont Biotech Inc Product containing Lactobacillus paracasei
WO2008042101A2 (en) * 2006-10-02 2008-04-10 Danisco A/S Probiotics for use in reducing the incidence and duration of illness
DE102006046960A1 (de) * 2006-10-04 2008-04-10 Euro Allianz Pharma Gmbh Gesundheitsfördernde Nahrungsmittelzusammensetzung
CN101190239B (zh) * 2006-11-28 2010-11-03 景岳生物科技股份有限公司 含有类干酪乳杆菌的产品
CA2705642A1 (en) * 2007-11-13 2009-05-22 Biotec Pharmacon Asa Methods of treating or preventing inflammatory diseases of the intestinal tract
IL199781A0 (en) 2009-07-09 2010-05-17 Yohai Zorea Heat resistant probiotic compositions and healthy food comprising them
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US8523837B2 (en) 2008-10-14 2013-09-03 Mead Johnson Nutrition Company Nutritive substance delivery container
US7823723B2 (en) 2008-10-14 2010-11-02 Mead Johnson Nutrition Company Nutritive substance delivery container
US8801688B2 (en) 2008-10-14 2014-08-12 Mead Johnson Nutrition Company Nutritive substance delivery container
US9474773B2 (en) * 2009-02-18 2016-10-25 University Of Florida Research Foundation, Inc. Lactobacillus supplement for alleviating type 1 diabetes
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN102802648A (zh) * 2009-05-11 2012-11-28 雀巢产品技术援助有限公司 约氏乳杆菌La1 NCC533(CNCM I-1225)和免疫病症
TWI482642B (zh) * 2009-05-27 2015-05-01 用於減敏療法之免疫調節製劑組合物及其劑型結構
US20110123677A1 (en) * 2009-11-25 2011-05-26 Pepsico, Inc. High acid beverage products and methods to extend probiotic stability
JP5932662B2 (ja) * 2009-12-22 2016-06-08 プロビ アクティエボラーグ 穀物ベースフラクション及びプロバイオティックを含む非発酵組成物、並びにそれらの使用
US20110293784A1 (en) 2010-05-28 2011-12-01 Anja Wittke Milk-based nutritional compositions
CN103096734B (zh) * 2010-05-28 2017-08-08 Mjn 美国控股有限责任公司 营养组合物
WO2012020403A1 (en) * 2010-08-09 2012-02-16 Degama Smart Ltd. Probiotic liquid food products
BR112013014044A2 (pt) 2010-12-06 2017-10-31 Degama Barrier Ltd composição, produto alimentício e processo para prepará-lo
WO2012076057A1 (en) * 2010-12-08 2012-06-14 Nestec S.A. Baby food products comprising hydrolysed whole grain
US20120171231A1 (en) * 2010-12-29 2012-07-05 Anja Wittke Use of nutritional compositions including lactoferrin in stimulating immune cells
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US20130095204A1 (en) * 2011-10-14 2013-04-18 Zeina Jouni Nutritional phytonutrient compositions
EP2604123A1 (de) 2011-12-15 2013-06-19 Friesland Brands B.V. Verfahren und Ernährungszusammensetzung zur Behandlung von Durchfall
KR101381794B1 (ko) * 2012-04-10 2014-04-07 씨제이제일제당 (주) 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물
JP6372890B2 (ja) * 2013-03-08 2018-08-15 学校法人東京理科大学 乳酸菌増殖促進剤、制御性ｔ細胞増加剤、乳酸菌増殖促進方法、制御性ｔ細胞を増加させる方法、制御性ｔ細胞増加効果の評価方法、および乳酸菌増殖促進効果の評価方法
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US10543175B1 (en) 2013-05-17 2020-01-28 Degama Berrier Ltd. Film composition and methods for producing the same
SG10201810886YA (en) 2013-08-26 2019-01-30 Meiji Co Ltd Antibody titer-increasing agent using lactic acid bacterium
WO2016108946A1 (en) * 2014-12-29 2016-07-07 Hill's Pet Nutrition, Inc. Food composition and method of use
KR101660764B1 (ko) * 2015-02-06 2016-10-05 인지전기공업 주식회사 베타글루칸 이유식 제조방법 및 이에 의해 제조된 베타글루칸 이유식
CN108076643B (zh) * 2015-06-29 2021-09-21 辉凌制药公司 用于治疗例如细菌性阴道病的鼠李糖乳杆菌细菌
CN107920575A (zh) * 2015-07-01 2018-04-17 裕得生物科技有限公司 一种合生素发酵产物的制造方法及由此制造的合生素发酵产物
NL2016115B1 (en) 2016-01-18 2017-07-25 Innoso B V Food composition with fermented starch.
US10576113B2 (en) 2016-04-19 2020-03-03 Akay Flavours & Aromatics Pvt, Ltd. Method of preparing stable, water soluble probiotic compositions based on millets and similar cereals
KR101684289B1 (ko) * 2016-05-17 2016-12-09 한국식품연구원 락토바실러스 sp. KCCM 11826P 균주를 이용한 고인산혈증 예방, 만성 신장질환 치료용 약학조성물 및 건강기능성 식품
US11197902B2 (en) * 2016-06-24 2021-12-14 Ig Biosciences Corporation Prebiotic neutraceutical compositions and methods of treatment using the same
CN107836707B (zh) * 2017-10-19 2020-09-08 广东省农业科学院蚕业与农产品加工研究所 一种具有改善糖脂代谢紊乱的健康食品基料的制备方法及应用
FI128699B (en) * 2017-12-22 2020-10-30 Valio Ltd Herbal food product and process
CN109757731A (zh) * 2019-03-14 2019-05-17 广州普维君健药业有限公司 缓解乳糖不耐的益生菌组合物及其制备方法和应用
KR102257769B1 (ko) * 2019-06-07 2021-05-28 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
KR102257768B1 (ko) * 2019-06-07 2021-05-28 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
KR102161552B1 (ko) * 2019-06-07 2020-10-05 (주)큐젠바이오텍 베타글루칸을 포함하는 장내 균총 개선용 조성물 및 이의 용도
CN111000246A (zh) * 2019-12-27 2020-04-14 汤臣倍健股份有限公司 一种辅助降甘油三酯的益生菌膳食纤维组合物及其应用、保健品
IT202100032279A1 (it) * 2021-12-22 2023-06-22 St Gentili S R L Vitexina o suo isomero per uso nel trattamento di ASD

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
US4874618A (en) 1985-12-27 1989-10-17 General Mills, Inc. Package containing a moisture resistant edible internal barrier
FI88856C (fi) 1990-05-18 1997-07-01 Alko Yhtioet Oy Foerfarande foer framstaellning av ett fermenterat, huvudsakligen pao havrekli baserat, levande mikroorganismer innehaollande livsmedel
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
AUPO430496A0 (en) 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
NL1010770C2 (nl) 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
US20020150658A1 (en) * 2001-04-16 2002-10-17 Clint Morrissette Food package containing food products in separate compartments separated by a burst seal and method of making
EP1429620A1 (de) * 2001-08-31 2004-06-23 Nutricopia, Inc. Gefrorene ernährungssüssspeisen und verfahren zu ihrer herstellung
US6835558B2 (en) * 2002-02-04 2004-12-28 General Mills, Inc. Beta-glucan compositions and process therefore
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
JP3889647B2 (ja) 2002-03-27 2007-03-07 株式会社Ａｄｅｋａ ヨーグルト類
EP1602377B1 (de) * 2003-03-07 2011-08-10 Aureo Co., Ltd. Zusammensetzung mit beta-glucan und obstipationslinderndes mittel, immunopotentiator und hautbefeuchtungsmittel unter verwendung der zusammensetzung
GB0308104D0 (en) * 2003-04-08 2003-05-14 Novartis Nutrition Ag Organic compounds
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür

Also Published As

Publication number Publication date
AU2006214382A1 (en) 2006-08-24
US8404228B2 (en) 2013-03-26
US20110274722A1 (en) 2011-11-10
US20080193485A1 (en) 2008-08-14
WO2006088923A2 (en) 2006-08-24
EP1858340B1 (de) 2010-07-14
AU2006214382B2 (en) 2011-06-02
JP2008529535A (ja) 2008-08-07
DK1858340T3 (da) 2010-09-27
EP1858340A2 (de) 2007-11-28
ES2348403T3 (es) 2010-12-03
AU2006214382C1 (en) 2012-03-08
KR101355266B1 (ko) 2014-02-06
EP1858340A4 (de) 2008-09-17
WO2006088923A3 (en) 2007-05-10
KR20070121641A (ko) 2007-12-27
JP4777365B2 (ja) 2011-09-21
EP2248430A2 (de) 2010-11-10
ATE473636T1 (de) 2010-07-15
US7981412B2 (en) 2011-07-19
EP2248430A3 (de) 2011-01-12

Similar Documents

Publication Publication Date Title
DE602006015438D1 (de) Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
BE2021C505I2 (de)
ZA200609378B (en) Molecularly imprinted polymers selective for nitrosamines and methods of using the same
DE602006016760D1 (de) Zusammensetzungen und verfahren zur kontrolle, prävention und behandlung von essstörungen
MA30153B1 (fr) Anticorps anti-ox40l et methodes correspondantes
HK1114099A1 (de)
ATE494275T1 (de) Herstellung von cis-pellitorin und verwendung als aromastoff
HK1125855A1 (en) Use of oligouronates for treating mucus hyperviscosity
MX2009005999A (es) Polimeros marcados molecularmente, selectivos para las nitrosaminas especificas del tabaco y metodo para utilizar los mismos.
DE602006009652D1 (de) Eine herstellungsmethode von entacapon-enthaltenden granulaten für orale dosierformen
MX2009013199A (es) Anticuerpos anti-notch1 nnr y sus metodos de uso.
IL173002A (en) Use of calcitonin in the manufacture of oral medication for the prevention or treatment of osteoarthritis
HK1119720A1 (en) Immunoglobulins directed against nogo
WO2007075852A3 (en) Calcium channel antagonists
IL213523A0 (en) Compositions comprising blood group antigens
MY147247A (en) Organic compounds and their uses
DE602006006068D1 (de) Verwendung von botulintoxin zur verbesserung der magenentleerung und/oder behandlung von gerd
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
UA89800C2 (en) Acylated nonadepsipeptides used as lysobactin derivatives
MX2007011264A (es) Composiciones nutricionales para modular la biodisponibilidad de vitamina c.
CY1113310T1 (el) Εξανθρωπισμενα αντισωματα ειδικα για nogo-a και φαρμακευτικες χρησεις αυτων
HK1154904A1 (zh) 天然 抗體及其抑制劑
MX2009009693A (es) Metodos para activar irs-1 y akt.